Association between serum tumor necrosis factor-alpha level and the efficacy of infliximab for refractory pouchitis after restorative proctocolectomy in patients with ulcerative colitis

Association between serum tumor necrosis factor-alpha level and the efficacy of infliximab for refractory pouchitis after restorative proctocolectomy in patients with ulcerative colitis

Objectives: Although the aetiology of pouchitis after restorative proctocolectomy in ulcerative colitis (UC) remains unknown, infliximab (IFX) is often effective for this condition. However, indicators and predictors of treatment efficacy remain unclear. In this study, the association between serum...

Full description

Bibliographic Details
Main Authors: Motoi Uchino, Hiroki Ikeuchi, Toshihiro Bando, Akihiro Hirata, Teruhiro Chohno, Hirofumi Sasaki, Yuki Horio, Shiro Nakamura
Format: Article
Language:English
Published: The Japan Society of Coloproctology 2017-10-01
Series:Journal of the Anus, Rectum and Colon
Subjects:
ulcerative colitis
pouchitis
tumor necrosis factor-alpha
infliximab
Online Access:https://www.jstage.jst.go.jp/article/jarc/1/4/1_2016-008/_pdf/-char/en

Internet

https://www.jstage.jst.go.jp/article/jarc/1/4/1_2016-008/_pdf/-char/en

Similar Items